Hassan Raza: The JAK2 V617F Revolution
Hassan Raza, Consultant Hematologist and Transfusion Medicine Specialist, shared a post on LinkedIn about a recent article by Ayalew Tefferi, published in Haematologica, adding:
”The JAK2 V617F Revolution: A Landmark in Hematology
‘If you want to discover new ideas, revisit old discoveries.’
The identification of JAK2 V617F in 2005 transformed our understanding of myeloproliferative neoplasms (MPNs), reshaping their diagnosis, classification, and therapeutic approaches.
A fascinating reflection on how a single molecular discovery changed hematology.
Worth revisiting: A landmark paper revisited by Ayalew Tefferi in Haematologica, November 2026.”
Title: The JAK2 V617F revolution in myeloproliferative neoplasms
Author: Ayalew Tefferi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian
-
Nov 11, 2026, 14:45ITP Is More Than a Platelet Count: Why Patient Perspectives Matter – ITP Australia and New Zealand
-
Nov 11, 2026, 14:27Aswin K Mohan։ Intravenous Iron in Heart Failure and Infection Risk
-
Nov 11, 2026, 14:12Thomas Lund: Advancing Home Treatment in Hematology Across Borders
-
Nov 11, 2026, 14:06Ahmed Alotaibi: The Hidden Iron Deficiency Behind a Normal Haemoglobin
-
Nov 11, 2026, 14:03Zain Khalpey: How Chronic Hypertension Reshapes the Heart
-
Nov 11, 2026, 13:52Vera Ignjatović: The Changing Balance of Hemostasis Across Childhood
-
Nov 11, 2026, 13:52Sariya Banday: Optimizing BCMA CAR-T Cells to Improve Persistence and Reduce Exhaustion
-
Nov 11, 2026, 13:46Danny Gaskin: Recognising Iron Deficiency Before Anaemia